tiprankstipranks
Trending News
More News >
Shandong Boan Biotechnology Company., Limited. Class H (HK:6955)
:6955
Hong Kong Market
6955
Shandong Boan Biotechnology Company., Limited. Class H
RESEARCH TOOLSreports
Advertisement

Shandong Boan Biotechnology Company., Limited. Class H (6955) Price & Analysis

Compare
1 Followers

6955 Stock Chart & Stats


Shandong Boan Biotechnology Company., Limited. Class H News

6955 FAQ

What was Shandong Boan Biotechnology Company., Limited. Class H’s price range in the past 12 months?
Shandong Boan Biotechnology Company., Limited. Class H lowest stock price was HK$7.51 and its highest was HK$25.00 in the past 12 months.
    What is Shandong Boan Biotechnology Company., Limited. Class H’s market cap?
    Shandong Boan Biotechnology Company., Limited. Class H’s market cap is HK$8.00B.
      When is Shandong Boan Biotechnology Company., Limited. Class H’s upcoming earnings report date?
      Shandong Boan Biotechnology Company., Limited. Class H’s upcoming earnings report date is Mar 30, 2026 which is in 204 days.
        How were Shandong Boan Biotechnology Company., Limited. Class H’s earnings last quarter?
        Shandong Boan Biotechnology Company., Limited. Class H released its earnings results on Aug 27, 2025. The company reported HK$0.044 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.044.
          Is Shandong Boan Biotechnology Company., Limited. Class H overvalued?
          According to Wall Street analysts Shandong Boan Biotechnology Company., Limited. Class H’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Shandong Boan Biotechnology Company., Limited. Class H pay dividends?
            Shandong Boan Biotechnology Company., Limited. Class H does not currently pay dividends.
            What is Shandong Boan Biotechnology Company., Limited. Class H’s EPS estimate?
            Shandong Boan Biotechnology Company., Limited. Class H’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Shandong Boan Biotechnology Company., Limited. Class H have?
            Shandong Boan Biotechnology Company., Limited. Class H has 622,333,700 shares outstanding.
              What happened to Shandong Boan Biotechnology Company., Limited. Class H’s price movement after its last earnings report?
              Shandong Boan Biotechnology Company., Limited. Class H reported an EPS of HK$0.044 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.794%.
                Which hedge fund is a major shareholder of Shandong Boan Biotechnology Company., Limited. Class H?
                Currently, no hedge funds are holding shares in HK:6955

                Shandong Boan Biotechnology Company., Limited. Class H Stock Smart Score

                4
                Neutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Positive
                20 days / 200 days
                Momentum
                40.89%
                12-Months-Change

                Fundamentals

                Return on Equity
                1.85%
                Trailing 12-Months
                Asset Growth
                37.41%
                Trailing 12-Months

                Company Description

                Shandong Boan Biotechnology Company., Limited. Class H

                Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. The company is engaged in the development, manufacture, and commercialisation of high quality biologics in China and worldwide. It focuses on areas such as oncology, metabolism, autoimmunity, and ophthalmology.

                Shandong Boan Biotechnology Company., Limited. Class H (6955) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Alphamab Oncology
                Ascletis Pharma, Inc.
                HBM Holdings Ltd.
                Abbisko Cayman Limited
                Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis